LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 6 of total 6

Search options

  1. Article ; Online: Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection.

    Herrera-Lasso Regás, Valeria / Dordal Culla, María Teresa / Lleonart Bellfill, Ramón

    Medicina clinica (English ed.)

    2020  Volume 155, Issue 10, Page(s) 448–453

    Abstract: Currently, there is no treatment approved for COVID-19. Numerous drugs are being used in an empirical manner according to experience and availability. Studies demonstrating their efficacy and safety are still to be published. Thus, it is of vital ... ...

    Abstract Currently, there is no treatment approved for COVID-19. Numerous drugs are being used in an empirical manner according to experience and availability. Studies demonstrating their efficacy and safety are still to be published. Thus, it is of vital importance for healthcare workers to be well informed and updated regarding possible immunological and non-immunological adverse effects regarding such treatments. In this narrative revision, the rationale use of these treatments in the SARS-CoV-2 infection is emphasized as well as their most frequently described adverse drug reactions. Drugs that are being essayed to counteract both clinical phases that are thought to take place in the severe stage of this disease are included; an initial phase where a viral infection prevails and a second phase where an inflammatory response takes over. Adverse reactions registered in the Pharmacovigilance Program of our hospital before the onset of this pandemic have also been included.
    Language English
    Publishing date 2020-10-30
    Publishing country Spain
    Document type Journal Article ; Review
    ISSN 2387-0206
    ISSN (online) 2387-0206
    DOI 10.1016/j.medcle.2020.06.026
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  2. Article ; Online: Reacciones adversas a fármacos utilizados en el tratamiento específico de la infección por SARS-CoV-2.

    Herrera-Lasso Regás, Valeria / Dordal Culla, María Teresa / Lleonart Bellfill, Ramón

    Medicina clinica

    2020  Volume 155, Issue 10, Page(s) 448–453

    Abstract: Currently, there is no treatment approved for COVID-19. Numerous drugs are being used in an empirical manner according to experience and availability. Studies demonstrating their efficacy and safety are still to be published. Thus, it is of vital ... ...

    Title translation Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection.
    Abstract Currently, there is no treatment approved for COVID-19. Numerous drugs are being used in an empirical manner according to experience and availability. Studies demonstrating their efficacy and safety are still to be published. Thus, it is of vital importance for healthcare workers to be well informed and updated regarding possible immunological and non-immunological adverse effects regarding such treatments. In this narrative revision, the rationale use of these treatments in the SARS-CoV-2 infection is emphasized as well as their most frequently described adverse drug reactions. Drugs that are being essayed to counteract both clinical phases that are thought to take place in the severe stage of this disease are included; an initial phase where a viral infection prevails and a second phase where an inflammatory response takes over. Adverse reactions registered in the Pharmacovigilance Program of our hospital before the onset of this pandemic have also been included.
    MeSH term(s) Anti-Inflammatory Agents/adverse effects ; Anti-Inflammatory Agents/therapeutic use ; Antiviral Agents/adverse effects ; Antiviral Agents/therapeutic use ; Humans ; Pharmacovigilance ; Treatment Outcome ; COVID-19 Drug Treatment
    Chemical Substances Anti-Inflammatory Agents ; Antiviral Agents
    Keywords covid19
    Language Spanish
    Publishing date 2020-07-09
    Publishing country Spain
    Document type Journal Article ; Review
    ZDB-ID 411607-0
    ISSN 1578-8989 ; 0025-7753
    ISSN (online) 1578-8989
    ISSN 0025-7753
    DOI 10.1016/j.medcli.2020.06.019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Ua VI Zs.279: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  3. Article: Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection

    Regás, Valeria Herrera-Lasso Culla María Teresa Dordal Bellfill Ramón Lleonart

    Medicina Clínica (English Edition)

    Abstract: Currently, there is no treatment approved for COVID-19 Numerous drugs are being used in an empirical manner according to experience and availability Studies demonstrating their efficacy and safety are still to be published Thus, it is of vital importance ...

    Abstract Currently, there is no treatment approved for COVID-19 Numerous drugs are being used in an empirical manner according to experience and availability Studies demonstrating their efficacy and safety are still to be published Thus, it is of vital importance for healthcare workers to be well informed and updated regarding possible immunological and non-immunological adverse effects regarding such treatments In this narrative revision, the rationale use of these treatments in the SARS-CoV-2 infection is emphasized as well as their most frequently described adverse drug reactions Drugs that are being essayed to counteract both clinical phases that are thought to take place in the severe stage of this disease are included;an initial phase where a viral infection prevails and a second phase where an inflammatory response takes over Adverse reactions registered in the Pharmacovigilance Program of our hospital before the onset of this pandemic have also been included Resumen Actualmente no hay ningún fármaco aprobado para el tratamiento de la COVID-19 Se emplean fármacos de manera empírica según experiencia y disponibilidad, pero no existen estudios controlados que demuestren su eficacia y seguridad En este contexto, es importante que los médicos dispongan de información de los posibles efectos adversos tanto inmunológicos como no inmunológicos de estos medicamentos En esta revisión se repasa el fundamento para su uso en la infección por SARS-Cov-2, así como las reacciones adversas más frecuentes;no se trata de una revisión sistemática sino narrativa Se han incluido aquellos fármacos que se utilizan con el fin de abordar adecuadamente las dos fases clínicas que parece tener la enfermedad en su manifestación más grave: una primera fase con predominio de infección viral y una segunda fase con predominio de una respuesta inflamatoria También se han repasado los casos de reacciones a dichos fármacos recogidas en el Programa de Farmacovigilancia del hospital antes del inicio de la pandemia
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #894118
    Database COVID19

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  4. Article ; Online: Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection

    Herrera-Lasso Regás, Valeria / Dordal Culla, María Teresa / Lleonart Bellfill, Ramón

    Medicina Clínica (English Edition) ; ISSN 2387-0206

    2020  

    Keywords covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    DOI 10.1016/j.medcle.2020.06.026
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    Full text online

    More links

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  5. Article ; Online: Reacciones adversas a fármacos utilizados en el tratamiento específico de la infección por SARS-CoV-2

    Herrera-Lasso Regás, Valeria / Dordal Culla, María Teresa / Lleonart Bellfill, Ramón

    Medicina Clínica ; ISSN 0025-7753

    2020  

    Keywords General Medicine ; covid19
    Language Spanish
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    DOI 10.1016/j.medcli.2020.06.019
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    Full text online

    More links

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  6. Article: Reacciones adversas a fármacos utilizados en el tratamiento específico de la infección por SARS-CoV-2./ Reacciones adversas a fármacos utilizados en el tratamiento específico de la infección por SARS-CoV-2./ Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection

    Herrera-Lasso Regás, Valeria / Dordal Culla, María Teresa / Lleonart Bellfill, Ramón

    Med. clin (Ed. impr.)

    Abstract: Currently, there is no treatment approved for COVID-19. Numerous drugs are being used in an empirical manner according to experience and availability. Studies demonstrating their efficacy and safety are still to be published. Thus, it is of vital ... ...

    Abstract Currently, there is no treatment approved for COVID-19. Numerous drugs are being used in an empirical manner according to experience and availability. Studies demonstrating their efficacy and safety are still to be published. Thus, it is of vital importance for healthcare workers to be well informed and updated regarding possible immunological and non-immunological adverse effects regarding such treatments. In this narrative revision, the rationale use of these treatments in the SARS-CoV-2 infection is emphasized as well as their most frequently described adverse drug reactions. Drugs that are being essayed to counteract both clinical phases that are thought to take place in the severe stage of this disease are included; an initial phase where a viral infection prevails and a second phase where an inflammatory response takes over. Adverse reactions registered in the Pharmacovigilance Program of our hospital before the onset of this pandemic have also been included.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #688860
    Database COVID19

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

To top